
JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure
2025-12-24 10:00:42JFL Life Sciences Ltd witnessed robust buying interest on 24 Dec 2025, hitting its upper circuit limit with a maximum daily gain of 4.76%. The stock closed at ₹15.40, marking a significant outperformance against its sector and broader market indices, driven by heightened investor participation and unfilled demand.
Read More
JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure
2025-12-23 11:00:14JFL Life Sciences Ltd witnessed a significant surge in trading activity on 23 Dec 2025, hitting its upper circuit price limit of ₹14.70, marking a maximum daily gain of 5.0%. This movement reflects robust buying interest in the stock within the Pharmaceuticals & Biotechnology sector, accompanied by a regulatory freeze on further transactions, resulting in unfilled demand and heightened market attention.
Read More
JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure
2025-12-22 10:00:40Shares of JFL Life Sciences Ltd surged to their upper circuit limit on 22 Dec 2025, reflecting robust buying interest and a maximum permissible daily gain of 5%. The stock outperformed its Pharmaceuticals & Biotechnology sector peers and broader market indices, signalling heightened investor enthusiasm despite a micro-cap market capitalisation of ₹45.86 crore.
Read More
JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure
2025-12-19 10:00:23JFL Life Sciences Ltd witnessed a significant surge in its share price on 19 Dec 2025, hitting the upper circuit limit of 13.35, marking a maximum daily gain of 4.71%. This movement was accompanied by robust buying interest and a notable rise in delivery volumes, reflecting heightened investor participation in the Pharmaceuticals & Biotechnology sector.
Read More
JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure
2025-12-18 10:00:24JFL Life Sciences Ltd witnessed a significant surge in trading activity on 18 Dec 2025, hitting its upper circuit price limit of ₹12.75. The stock recorded a maximum daily gain of 4.94%, outperforming its sector and broader market indices, driven by robust buying interest and a notable rise in delivery volumes.
Read More
JFL Life Sciences Hits Lower Circuit Amid Heavy Selling Pressure
2025-12-10 14:00:08Shares of JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, plunged to their new 52-week and all-time low of ₹11.25 on 10 Dec 2025, hitting the lower circuit limit amid intense selling pressure and subdued investor participation.
Read More
JFL Life’s Evaluation Metrics Revised Amid Mixed Performance in Pharmaceuticals Sector
2025-12-07 10:10:30JFL Life, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its evaluation metrics, reflecting nuanced shifts across key analytical parameters. This update comes amid a challenging market environment where the stock has experienced significant volatility and a prolonged downward trend over the past year.
Read More
JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure
2025-12-05 14:00:12JFL Life Sciences Ltd witnessed a significant surge in its share price on 5 Dec 2025, hitting the upper circuit limit of 5%, closing at ₹11.95. This movement was driven by robust buying interest, resulting in a maximum daily gain of 4.82%, outperforming its sector and broader market indices.
Read More
JFL Life Sciences Hits Upper Circuit Amidst Unprecedented Buying Interest
2025-12-05 13:26:12JFL Life Sciences Ltd witnessed extraordinary buying momentum on 5 Dec 2025, hitting the upper circuit with only buy orders in the queue and no sellers present. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike.
Read MoreCorporate Actions
No Upcoming Board Meetings
JFL Life Sciences Ltd has declared 2% dividend, ex-date: 13 Sep 24
No Splits history available
JFL Life Sciences Ltd has announced 2:1 bonus issue, ex-date: 24 Sep 24
No Rights history available






